+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biopolymers for Medical Applications Market by Application, Type, Form, End User, Production Method - Global Forecast to 2030- Product Image
Biopolymers for Medical Applications Market by Application, Type, Form, End User, Production Method - Global Forecast to 2030- Product Image
Sale

Biopolymers for Medical Applications Market by Application, Type, Form, End User, Production Method - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4829857
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Biopolymers for Medical Applications Market is undergoing rapid advancement, transforming clinical practice through new material solutions and process innovations. Senior decision-makers seeking enduring growth strategies must understand the interplay between evolving regulatory demands, technological progress, and shifting global trade policies.

Market Snapshot: Biopolymers for Medical Applications

This market expanded from USD 3.00 billion in 2024 to USD 3.73 billion in 2025 and is forecasted to reach USD 10.55 billion by 2030, progressing at a 23.30% CAGR. Rising clinical expectations, along with continuous advancements in medical-grade polymer chemistry and manufacturing, are increasing demand for biocompatible and sustainable materials. Regulatory agencies are refining approval processes and global guidelines, driving strategic investments and competitive re-alignment across key players.

Scope & Segmentation

The report provides a precise breakdown of the medical biopolymers landscape, analyzing key applications, types, forms, end users, production methods, regions, and leading industry participants.

  • Applications: Cardiovascular devices, dental solutions, drug delivery films, microspheres, nanoparticles, ophthalmic, orthopedic, surgical sutures, tissue engineering (bone, cartilage, skin), wound dressings
  • Type: Alginate, chitosan, collagen, hyaluronic acid, polyhydroxyalkanoates (including PHB, PHV), polylactic acid
  • Form: Fibers, films, hydrogels, microspheres, scaffolds (electrospun and printed)
  • End User: Contract research organizations, hospitals and clinics, pharmaceutical companies, research laboratories
  • Production Method: Chemical synthesis, extraction, fermentation
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Companies: Evonik Industries AG, Corbion N.V., NatureWorks LLC, Cargill, Incorporated, DuPont de Nemours, Inc., Koninklijke DSM N.V., Tepha, Inc., Poly-Med, Inc., Sigma-Aldrich Corporation, Danimer Scientific, Inc.

Key Takeaways for Strategic Leadership

  • Technological innovation in polymer chemistry is supporting the launch of advanced, customizable medical materials for targeted therapeutic use and device integration.
  • Strong collaboration between industry, research, and regulatory authorities is compressing the innovation cycle and fostering rapid translation to clinical adoption.
  • Sustainability is influencing decisions across the supply chain, with producers investing in greener extraction and fermentation processes to align with circular economy principles.
  • Segment and regional adoption patterns vary widely: North America leads in regulatory compliance and early technology implementation, while Asia-Pacific drives volume growth through manufacturing scale and policy support.
  • Mid-sized players are using agile production and customization capabilities to capture specialized market segments, whereas established companies focus on broad pipelines and compliance strength.
  • Strategic partnerships, licensing, and acquisitions remain integral for capacity expansion and portfolio diversification, creating a dynamic competitive environment.

Tariff Impact: Navigating US Trade Challenges

New cumulative tariffs from the United States in 2025 have raised production costs for raw and semi-processed biopolymer inputs. This has driven manufacturers to adjust sourcing strategies and adopt dual-sourcing or nearshoring to counteract cost volatility. Domestic investment in fermentation and synthesis facilities is rising, diversifying regional supply and mitigating single-point trade risks. Tariff-induced shifts are prompting both immediate cost management and long-term supply chain resilience.

Methodology & Data Sources

Insights are grounded in primary interviews with materials scientists, regulatory experts, and procurement leaders, supplemented by secondary research from journals, white papers, patent filings, clinical registries, and trade association publications. Consistent triangulation and transparent documentation practices underpin the credibility of all findings.

Why This Report Matters

  • Enables decision-makers to understand biopolymer technology adoption, market drivers, and tailored growth opportunities across applications and regions.
  • Equips leadership with actionable analysis of supply chain and regulatory dynamics, including the effect of tariffs and sustainability trends.
  • Supports investment prioritization and risk management by delivering reliable data and strategic recommendations relevant to competitive positioning.

Conclusion

The biopolymers for medical applications market is evolving, shaped by technology, regulation, and global trade dynamics. Stakeholders who act with agility and strategic vision will secure strong positions as standards and patient needs continue to change.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biopolymers for Medical Applications Market, by Application
8.1. Introduction
8.2. Cardiovascular Devices
8.3. Dental Applications
8.4. Drug Delivery
8.4.1. Films
8.4.2. Microspheres
8.4.3. Nanoparticles
8.5. Ophthalmic Devices
8.6. Orthopedic Devices
8.7. Surgical Sutures
8.8. Tissue Engineering
8.8.1. Bone Tissue
8.8.2. Cartilage
8.8.3. Skin Tissue
8.9. Wound Dressing
9. Biopolymers for Medical Applications Market, by Type
9.1. Introduction
9.2. Alginate
9.3. Chitosan
9.4. Collagen
9.5. Hyaluronic Acid
9.6. Polyhydroxyalkanoates
9.6.1. Phb
9.6.2. Phv
9.7. Polylactic Acid
10. Biopolymers for Medical Applications Market, by Form
10.1. Introduction
10.2. Fibers
10.3. Films
10.4. Hydrogels
10.5. Microspheres
10.6. Scaffolds
10.6.1. Electrospun Scaffolds
10.6.2. Printed Scaffolds
11. Biopolymers for Medical Applications Market, by End User
11.1. Introduction
11.2. Contract Research Organizations
11.3. Hospitals And Clinics
11.4. Pharmaceutical Companies
11.5. Research Laboratories
12. Biopolymers for Medical Applications Market, by Production Method
12.1. Introduction
12.2. Chemical Synthesis
12.3. Extraction
12.4. Fermentation
13. Americas Biopolymers for Medical Applications Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Biopolymers for Medical Applications Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Biopolymers for Medical Applications Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Evonik Industries AG
16.3.2. Corbion N.V.
16.3.3. NatureWorks LLC
16.3.4. Cargill, Incorporated
16.3.5. DuPont de Nemours, Inc.
16.3.6. Koninklijke DSM N.V.
16.3.7. Tepha, Inc.
16.3.8. Poly-Med, Inc.
16.3.9. Sigma-Aldrich Corporation
16.3.10. Danimer Scientific, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET MULTI-CURRENCY
FIGURE 2. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET MULTI-LANGUAGE
FIGURE 3. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CARDIOVASCULAR DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DENTAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FILMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY OPHTHALMIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY ORTHOPEDIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SURGICAL SUTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BONE TISSUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CARTILAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SKIN TISSUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY WOUND DRESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY ALGINATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CHITOSAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PHB, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PHV, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FIBERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FILMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY HYDROGELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY ELECTROSPUN SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRINTED SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY EXTRACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FERMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 71. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 73. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 74. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 76. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 77. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 78. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 80. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 82. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 83. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 85. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 86. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 87. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 126. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 128. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 129. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 131. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 132. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 133. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 135. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 137. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 138. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 140. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 141. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 142. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 153. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 155. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 156. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 157. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 158. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 159. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 160. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 162. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 164. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 165. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 166. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 167. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 168. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 169. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 180. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 182. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 183. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 185. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 186. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 189. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 191. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 192. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 193. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 194. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 195. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 198. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 200. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 201. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 202. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 203. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 204. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 205. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 209. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 210. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 211. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 212. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 213. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 214. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 216. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 218. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 219. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 220. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 221. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 222. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 223. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 225. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 227. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 228. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 229. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 230. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 231. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 232. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 234. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 236. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 237. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 238. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 239. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 240. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 241. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 245. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 246. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 247. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 248. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 249. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 250. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 252. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 254. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 255. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 256. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 257. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 258. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 259. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 261. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 263. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 264. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 265. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 266. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 267. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 268. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 270. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 272. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 273. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 274. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 275. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 276. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 277. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 279. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 281. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 282. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 283. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 284. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 285. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 286. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 288. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 290. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 291. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 292. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 293. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLIO

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Biopolymers for Medical Applications market report include:
  • Evonik Industries AG
  • Corbion N.V.
  • NatureWorks LLC
  • Cargill, Incorporated
  • DuPont de Nemours, Inc.
  • Koninklijke DSM N.V.
  • Tepha, Inc.
  • Poly-Med, Inc.
  • Sigma-Aldrich Corporation
  • Danimer Scientific, Inc.

Table Information

Report AttributeDetails
No. of Pages194
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.73 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.55 Billion
Compound Annual Growth Rate23.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Biopolymers Market by Type, Application, End Use Industry, Process Type - Global Forecast to 2030 - Product Image

Biopolymers Market by Type, Application, End Use Industry, Process Type - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Aerobically Degradable Biopolymer Market by Application, Type, End Use, Form, Production Process - Global Forecast to 2030 - Product Image

Aerobically Degradable Biopolymer Market by Application, Type, End Use, Form, Production Process - Global Forecast to 2030

  • Report
  • 199 Pages
  • Global
From
Bioplastics and Biopolymers - Global Strategic Business Report - Product Image

Bioplastics and Biopolymers - Global Strategic Business Report

  • Report
  • 452 Pages
  • Global
From
Lignin-based Biopolymers Market Size, Share & Trends Analysis Report by Product Type (Lignosulfonates, Kraft Lignin, Organosolv Lignin, Hydrolyzed Lignin), End-use (Automotive, Construction, Packaging, Agriculture), Region, with Growth Forecasts, 2025-2030 - Product Image

Lignin-based Biopolymers Market Size, Share & Trends Analysis Report by Product Type (Lignosulfonates, Kraft Lignin, Organosolv Lignin, Hydrolyzed Lignin), End-use (Automotive, Construction, Packaging, Agriculture), Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Polymers & Biopolymers In Beauty & Personal Care Products Market Size, Share & Trends Analysis Report By Function (Conditioning, Styling, Rheology Modifying), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Polymers & Biopolymers In Beauty & Personal Care Products Market Size, Share & Trends Analysis Report By Function (Conditioning, Styling, Rheology Modifying), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 145 Pages
  • Global
From

About the Medical Biopolymer Market

Medical biopolymers are bioplastics used in the medical industry. They are biodegradable, biocompatible, and non-toxic materials that can be used in a variety of medical applications, such as implants, prosthetics, and drug delivery systems. Medical biopolymers are typically derived from renewable sources, such as corn, sugarcane, and other plant-based materials. They are also often used in combination with other materials, such as metals, ceramics, and polymers, to create more complex medical devices. Medical biopolymers offer a number of advantages over traditional materials, such as improved biocompatibility, reduced risk of infection, and improved durability. They are also more cost-effective than traditional materials, making them attractive to medical device manufacturers. Some of the major companies in the medical biopolymer market include BASF, DowDuPont, Corbion, NatureWorks, and Novamont. These companies produce a variety of biopolymers for medical applications, including polylactic acid, polyhydroxyalkanoates, and polycaprolactone. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.